EQUITY (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK

	Number of underlying common stock		Weighted average exercise price
Series E Warrants		198,159	$	27.000
Series F Warrants		433,878	$	7.425
Series G Warrants		1,092,344	$	10.230
Underwriter Warrants		18,277	$	7.425
Other warrants		51,157	$	225.000 and above
Total Warrants		1,793,815	$

SCHEDULE OF STOCK OPTIONS GRANTED

INSPIREMD, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (continued)

NOTE 7 – EQUITY (continued):

5) The following table summarizes information about stock options granted to employees:

	Year ended December 31
	2022					2021
	Number of options			Weighted average exercise price		Number of options			Weighted average exercise price
Outstanding - beginning of period		289,408			5.29		91,692		$	6.20
Granted		7,841			2.61		205,223			4.90
Forfeited		(2,537	)		5.70		(7,507	)		5.69
Outstanding- end of period		294,712			5.21		289,408		$	5.29
Exercisable at the end of the period		123,115			5.51		28,360			6.26

6) The following table summarizes information about stock options granted to non-employees:

	Year ended December 31
	2022				2021
	Number of options		Weighted average exercise price		Number of options		Weighted average exercise price
Outstanding - beginning of period		20,002		6.90		-		-
Granted		146,667		2.89		20,002		6.90
Forfeited		-		-		-		-
Exercised		-		-		-		-
Outstanding - end of period		166,669		3.37		20,002		6.90
Exercisable at the end of the period		35,667		3.61		-		-

SCHEDULE OF RESTRICTED STOCK GRANTED TO EMPLOYEES

	Year ended December 31
	2022			2021
	Number of restricted stock
Outstanding - beginning of period		527,668			185,725
Reverse Split Adjustments		-			59
Granted		45,494			419,943
Forfeited		(10,832	)		(20,822	)
Vested		(206,379	)		(57,237	)
Outstanding - end of period		355,951			527,668

SCHEDULE OF RESTRICTED STOCK UNIT GRANTED TO EMPLOYEES

	Year ended December 31
	2022		2021
	Number of RSUs
Outstanding - beginning of period		237,078		90,511
Granted		-		146,567
Forfeited		-		-
Vested		-		-
Outstanding - end of period		237,078		237,078

SCHEDULE OF ADDITIONAL INFORMATION ABOUT ALL OPTIONS OUTSTANDING AND EXERCISABLE

				Outstanding as of December 31, 2022
Exercise price		Options outstanding		Weighted average remaining contractual life (years)		Options exercisable
$	2.61-2.97		154,508		9.25		29,000
$	3.89-4.12		146,347		8.81		48,782
$	4.95-10.05		156,473		8.00		78,298
$	16.50		4,053		7.01		2,702
			461,381		8.67		158,782

SCHEDULE OF FAIR VALUE OF OPTIONS GRANTED TO EMPLOYEES

	Year ended December 31
	2022	2021
Expected life	5.125-6.5 years	5.5-6.5 years
Risk-free interest rates	1.79%-2.88%-	0.59%-1.40%
Volatility	127.43%-130.93%	129.11%-136.78%
Dividend yield	-	-

SCHEDULE OF ALLOCATION OF TOTAL SHARE-BASED COMPENSATION EXPENSE

	Year ended December 31
	2022		2021
	($ in thousands)
Cost of revenues	$	72	$	49
Research and development		582		64
Sales and marketing		318		182
General and administrative		1,380		1,281
	$	2,352	$	1,576